PMID- 34281386 OWN - NLM STAT- MEDLINE DCOM- 20211231 LR - 20220519 IS - 2150-7511 (Electronic) VI - 12 IP - 4 DP - 2021 Aug 31 TI - Absence of CD28-CTLA4-PD-L1 Costimulatory Molecules Reduces Herpes Simplex Virus 1 Reactivation. PG - e0117621 LID - 10.1128/mBio.01176-21 [doi] LID - e01176-21 AB - We previously reported that herpes simplex virus 1 (HSV-1) ICP22 binds to CD80 and suppresses CD80 expression in vitro and in vivo. Similar to ICP22, the cellular costimulatory molecules CD28, CTLA4, and PD-L1 also bind to CD80. In this study, we asked whether, similar to ICP22-null virus, the absence of these costimulatory molecules will reduce HSV-1 infectivity. To test our hypothesis, CD28(-/-), CD28(-/-) CTLA4(-/-), PD-L1(-/-), and wild-type control BALB/c mice were ocularly infected with HSV-1 strain KOS. Levels of virus replication in the eye, corneal scarring (CS), latency, and reactivation in infected mice were determined. Expression of different genes in the trigeminal ganglia (TG) of latently infected mice was also determined by NanoString and quantitative reverse transcription-PCR (qRT-PCR). In the absence of costimulatory molecules, latency levels were higher than those in wild-type control mice, but despite higher latency, a significant number of TG from infected knockout mice did not reactivate. Reduced reactivation correlated with downregulation of 26 similar cellular genes that are associated with inflammatory signaling and innate immune responses. These results suggest that lower reactivation directly correlates with lower expression of interferon signaling. Thus, despite having different modes of actions, we identified a similar function for CD28, CTLA4, and PD-L1 in HSV-1 reactivation that is dependent on their interactions with CD80. Therefore, blocking these interactions could be a therapeutic target for HSV-1-induced reactivation. IMPORTANCE Costimulatory molecules play an important role in activation of T cell responses, and T cells contribute to HSV-1-induced eye disease in the host. Similar to HSV-1 ICP22, the cellular costimulatory molecules CD28, CTLA4, and PD-L1 also bind to CD80. In this study, we have shown that the absence of these costimulatory molecules significantly reduced HSV-1 ex vivo reactivation. Therefore, inhibiting the binding of costimulatory molecules to CD80 could be used to reduce reactivation and, consequently, HSV-1-induced eye disease. FAU - Matundan, Harry H AU - Matundan HH AD - Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns & Allen Research Institute, Los Angeles, California, USA. FAU - Jaggi, Ujjaldeep AU - Jaggi U AD - Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns & Allen Research Institute, Los Angeles, California, USA. FAU - Yu, Jack AU - Yu J AD - Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns & Allen Research Institute, Los Angeles, California, USA. FAU - Akbari, Omid AU - Akbari O AD - Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. FAU - Ghiasi, Homayon AU - Ghiasi H AD - Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns & Allen Research Institute, Los Angeles, California, USA. LA - eng GR - R01 HL144790/HL/NHLBI NIH HHS/United States GR - R01 EY029160/EY/NEI NIH HHS/United States GR - R01 EY024649/EY/NEI NIH HHS/United States GR - R01 HL151493/HL/NHLBI NIH HHS/United States GR - R01 EY026944/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20210720 PL - United States TA - mBio JT - mBio JID - 101519231 RN - 0 (B7-H1 Antigen) RN - 0 (CD28 Antigens) RN - 0 (CTLA-4 Antigen) RN - 0 (Cd274 protein, mouse) RN - 0 (Ctla4 protein, mouse) SB - IM MH - Animals MH - B7-H1 Antigen/*genetics MH - CD28 Antigens/*genetics MH - CTLA-4 Antigen/*genetics MH - Eye/virology MH - Female MH - Herpes Simplex/virology MH - Herpesvirus 1, Human/genetics/*physiology MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Mice, Knockout MH - Trigeminal Ganglion/virology MH - Virus Activation/*genetics MH - Virus Latency MH - Virus Replication/genetics PMC - PMC8406230 OTO - NOTNLM OT - HSV-1 OT - antigen-presenting cells OT - corneal scarring OT - knockout OT - latency OT - ocular infection OT - reactivation EDAT- 2021/07/21 06:00 MHDA- 2022/01/01 06:00 PMCR- 2021/07/20 CRDT- 2021/07/20 05:27 PHST- 2021/07/21 06:00 [pubmed] PHST- 2022/01/01 06:00 [medline] PHST- 2021/07/20 05:27 [entrez] PHST- 2021/07/20 00:00 [pmc-release] AID - mBio01176-21 [pii] AID - 10.1128/mBio.01176-21 [doi] PST - ppublish SO - mBio. 2021 Aug 31;12(4):e0117621. doi: 10.1128/mBio.01176-21. Epub 2021 Jul 20.